The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): Clinical-pathological characterization

Pigment Cell Research

Volumn 13, Issue 1, 2000, Pages 39-46

  Fleury, Catherine ^a,b   Bérard, Frederic ^a,c   Balme, Brigitte ^c   Thomas, Luc ^a,c  

^a INSERM   (France)

^b VETAGRO SUP   (France)

^c HÔTEL DIEU   (France)

Author keywords

Apocrine sweat glands; Cutaneous melanomas; Gray skinned horse; Pathology; Pigment cell tumors

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0342979872     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2000.130108.x     Document Type: Article

References (29)

1. Valentine BA. Equine melanocytic tumors: a retrospective study of 53 horses. J Vet Intern Med 1995;9:291-297
2. Fleury C.F., F. Bérard, A. Leblond, C. Faure, N. Ganem, L. Thomas (2000) Study of cutaneous melanoma in Camargue-type gray-skinned horse: (2) Epidemiological survey. Pigment Cell Res. 13:(in press).
3. Bonesi GL, Bracarense A, Minelli L. Melanomas in horses with light-colored fur - frequency distribution and lesions in carcasses. Anais Brasileiros de Dermatologia 1998;73:533-538
4. Fadyean MJ. Equine melanomatosis. J Comp Pathol Ther 1933;46:186-204
5. Foley GL, Valentine BA, Kincaid AL. Congenital and acquired melanocytomas (benign melanomas) in eighteen young horses. Vet Pathol 1991;28:363-369
6. Gorham S, Robl M. Melanoma in the gray horse: the dark side of equine aging. Equine Pract 1993:81:446-448
7. Priester WA. The occurence of cancer in domestic animals. Natl Cancer Inst Monogr 1980;54:31-164
8. Pulley LT, Stannard AA@. Tumors in domestic animals. 3rd ed. Jack E Moulton: 1990; 75-87.
9. Baptiste KE, Moll HD, Robertson JL. Three horses with neoplasia including growth in the guttural pouch. Can Vet J 1996;37:499-501
10. Cox JH, De Bowes RM, Leipold HW. Congenital malignant melanoma in two foals. J Am Vet Med Assoc 1989;194:945-947
11. Honnas CM, Liskry CC, Meagher DM, Brown D, Luck EE. Malignant melanoma in the foot of a horse. J Am Vet Med Assoc 1990;197:756-758
12. Thomas L, Tranchand P, Bérard F, Secchi T, Colin C, Moulin G. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998;197:11-17
13. Blanchard TL, Schumacher J, Edwards JF, Varner DD, Lewis RD, Everett K, Joyce JR. Priapism in a stallion with generalized malignant melanoma. J Am Vet Med Assoc 1991;198:1043-1044
14. Goetz TE, Ogilvie GK, Keegan KG, Johnson PJ. Cimetidine for treatment of melanomas in three horses. J Am Vet Med Assoc 1990;196:449-452
15. Mair TS, Pearson G. Melanotic hamartoma of the hind brain in a riding horse. J Comp Pathol 1990;102:239-243
16. Schott HC, Grant BD, Bayly WM. Melanoma as a cause of spinal cord compression in two horses. J Am Vet Med Assoc 1990;196:1820-1822
17. Cochran AJ, Bailly C, Cook M, Crotty K, McCarthy S, Mihm Jr MC, Mooi W, Sagebiel R. Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Hum Pathol 1997;28:1123-1125
18. Cochran AJ, Bailly C, Cook M, Crotty K, McCarthy S, Mihm Jr MC, Mooi W, Sagebiel R. Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Am J Clin Pathol 1998;110:719-722
19. Thomas I, Cochran AJ. Prise en charge du mélanome cutané. Cancer Radiother 1998;2:732-746
20. Thomas I, Bérard F, Secchi T. Diagnostic du mélanome cutané. Bull Esthet Dermatol Cosmetol 1996;4:65-74
21. Crowson NA, Magro CM, Mihm Jr MC. Malignant melanoma with prominent pigment synthesis: 'animal type' Melanoma. A clinical and histological study of six cases with consideration of other melanocytic neoplasms with prominent piement synthesis. Hum Pathol 1999;30:543-550
22. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the (3 subunit with tumor progression. Cancer Res 1990;50:6757-6764
23. Berthier-Vergnes O, Zebda N, Bailly M, Bailly C, Dore JF, Thomas L, Cochran AJ. Expression of peanut agglutinin-binding glycoconjugates in primary melanomas with high risk of metastases. Lancet 1993;341(8855):291
24. Cochran AJ, Wen DR, Berthier-Vergnes O, Bailly C, Dore JF, Berard F, Moulin G, Thomas L. Cytoplasmic accumulation of peanut agglutinin-binding glycoconjugates in the cells of primary melanoma correlates with clinical outcome. Hum Pathol 1999;30:556-561
25. Etoh T, Thomas L, Pastel Levy C, Colvin RB, Mihm Jr MC, Byers HR. Role of integrin α-2 β-1 (VLA-2) in the migration of human melanoma cells on laminin and type IV collagen. J Invest Dermatol 1993;100:640-647
26. Liotta LA, Wewer U, Rao NC, Schiffman E, Stracke M, Guirguis R, Thorgeirsson U, Muschel R, Sobel M. Biochemical mechanisms of tumor invasion and metastases. Adv Exp Med Biol 1988;233:161-169
27. Thomas L. CD44, the hyaluronate receptor: a role in cancer invasive and metastatic properties. Bull Cancer 1993;80:833-844
28. Thomas L, Byers H, Vink J, Stamenkovic L. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 1992;118:971-977
29. Barnhill RL, Piepkorn MW, Cochran AJ, Flynn E, Karaoli T, Folkman J. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998;134:991-994